Induction of functional erythropoietin and erythropoietin receptor gene expression by gamma-aminobutyric acid and piperine in kidney epithelial cells

Life Sci. 2018 Dec 15:215:207-215. doi: 10.1016/j.lfs.2018.11.024. Epub 2018 Nov 12.

Abstract

Aims: The aim of this study was to evaluate gamma-aminobutyric acid (GABA)- and piperine-induced erythropoietin (EPO) and EPO-receptor expression.

Materials and methods: The effect of GABA and piperine on cell viability was examined using kidney epithelial cells. Expression levels of EPO and EPO-R mRNA and protein were evaluated in response to GABA and piperine treatments. GABA- and piperine-mediated activation of the mitogen-activated protein kinase (MAPK) signaling pathway was investigated. Additionally, EPO function was evaluated using conditioned media containing EPO. The GABA receptor type involved in this process was identified.

Key findings: Messenger RNA and protein expression levels of EPO and EPO-R significantly increased in response to treatment with GABA, piperine, or the combination of both, compared with control. GABA plus piperine synergistically enhanced EPO and EPO-R expression through p38 and c-Jun N-terminal kinase (JNK) MAPK signaling pathways, but not through the extracellular signal-regulated kinase (ERK) MAPK pathway. SB203580 and SP600125 (p38 and JNK pathway inhibitors, respectively) attenuated GABA plus piperine-induced EPO and EPO-R expression. Treatment of macrophages with EPO-containing conditioned media induced mRNA expression of interleukin (IL)-10 and nuclear factor (NF)-κB due to the interaction between EPO and EPO-R. Interestingly, GABA-induced EPO and EPO-R expression was mediated through GABAA, not GABAB, receptor activation.

Significance: These findings demonstrate that GABA plus piperine-mediated p38 and JNK MAPK activation increases EPO and EPO-R expression, resulting in up-regulation of IL-10 and NF-κB.

Keywords: Erythropoietin; Gamma-aminobutyric acid; MAPK; Piperine; Signal transduction.

MeSH terms

  • Alkaloids / administration & dosage
  • Alkaloids / pharmacology*
  • Animals
  • Benzodioxoles / administration & dosage
  • Benzodioxoles / pharmacology*
  • Cell Line
  • Cell Survival / drug effects*
  • Drug Synergism
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Erythropoietin / genetics*
  • Gene Expression Regulation / drug effects
  • Interleukin-10 / genetics
  • Kidney / drug effects
  • Kidney / metabolism
  • LLC-PK1 Cells
  • MAP Kinase Signaling System / drug effects
  • NF-kappa B / genetics
  • Piperidines / administration & dosage
  • Piperidines / pharmacology*
  • Polyunsaturated Alkamides / administration & dosage
  • Polyunsaturated Alkamides / pharmacology*
  • RNA, Messenger / metabolism
  • Receptors, Erythropoietin / genetics*
  • Swine
  • Up-Regulation / drug effects
  • gamma-Aminobutyric Acid / administration & dosage
  • gamma-Aminobutyric Acid / pharmacology*

Substances

  • Alkaloids
  • Benzodioxoles
  • NF-kappa B
  • Piperidines
  • Polyunsaturated Alkamides
  • RNA, Messenger
  • Receptors, Erythropoietin
  • Erythropoietin
  • Interleukin-10
  • gamma-Aminobutyric Acid
  • piperine